Matthew Lunning, MD, FACP

University of Nebraska Medical Center

Poster(s):

• (SLB-025) Second Primary Malignancy in Patients with Diffuse Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy and Other Systemic Anti-Cancer Therapy: A Real-World Evidence from a Large US National Claims Database
  Monday, August 25, 2025

  11:45 AM - 12:45 PM ET